L859-0931 Screening compound: 2-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-methyl-N-phenylacetamide

L859-0931 Screening compound: 2-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-methyl-N-phenylacetamide
L859-0931 Screening compound: 2-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-methyl-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L859-0931
2-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-methyl-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L859-0931

Molecular Formula

C26H20FN5O3 (C26 H20 FN5 O3)

Compound Name

2-{3-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridin-1-yl}-N-methyl-N-phenylacetamide

IUPAC name

2-{3-[3-(4-fluorophenyl)-124-oxadiazol-5-yl]-7-methyl-4-oxo-14-dihydro-18-naphthyridin-1-yl}-N-methyl-N-phenylacetamide

SMILES

Cc(cc1)nc(N(CC(N(C)c2ccccc2)=O)C=C2c3nc(-c(cc4)ccc4F)no3)c1C2=O

InChI

InChI=1S/C26H20FN5O3/c1-16-8-13-20-23(34)21(26-29-24(30-35-26)17-9-11-18(27)12-10-17)14-32(25(20)28-16)15-22(33)31(2)19-6-4-3-5-7-19/h3-14H,15H2,1-2H3

InChI Key

VWRLNZOGHVJQPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27481395

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

469.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.379

Distribution Coefficient, logD

4.379

Water Solubility, LogSw

-4.48

Polar Surface Area

71.787

Acid Dissociation Constant (pKa)

18.61

Base Dissociation Constant (pKb)

-0.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

11.50

L859-0931 in Drug Discovery

Included in Screening Libraries

C-Met Library (15277 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L859-0931 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L859-0931?
Check Price and Availability of L859-0931, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L859-0931 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L859-0931
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L859-0931
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L859-0931 available by request